NYSE:PFE
Pfizer Stock News
$28.64
-0.280 (-0.97%)
At Close: May 17, 2024
6 Blue Chip Dividend Stocks to Buy in March
01:15pm, Tuesday, 12'th Mar 2024
The company's core business is leasing space on its wireless towers, primarily to wireless carriers, government agencies, and broadband data providers.
What To Know About Adcetris—Pfizer's Cancer Drug Extended Survival For Patients With Common Lymphoma
11:10am, Tuesday, 12'th Mar 2024
Pfizer's cancer drug Adcetris extended survival in patients with a common form of lymphoma in a late-stage trial, the company announced Tuesday, supporting Pfizer's efforts to expand into cancer treat
Pfizer: It's Darkest Before The Dawn, Upgrading To 'Strong Buy'
09:10am, Tuesday, 12'th Mar 2024
Pfizer's Q4 FY2023 financials show a significant downturn in consolidated revenues, with a 93% decline in profit for the full year. Sales of Comirnaty and Paxlovid, Pfizer's COVID-related drugs, fell
Pfizer's drug meets main goal in late-stage blood cancer trial
07:00am, Tuesday, 12'th Mar 2024
Pfizer said on Tuesday a combination treatment using its drug, Adcetris, met its main goal of overall survival when tested in patients with a type of blood cancer.
Looking To Start Earning Passive Income in March? Here Are 6 Top Dividend Stocks
02:45pm, Monday, 11'th Mar 2024
Are you ready for retirement? Planning for retirement can be overwhelming, that's why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Pfizer bets on cancer drugs to recover from rapid decline of COVID business
11:57am, Monday, 11'th Mar 2024
Pfizer is pushing to be more involved in cancer drugs after a turbulent year marked by the rapid decline of its COVID business. During a four-hour investor event last week, Pfizer pushed its initative
2 Dirt Cheap Dividend Stocks to Buy and Hold
09:45am, Monday, 11'th Mar 2024
Pfizer's slumping revenue is a temporary hiccup considering its incredibly deep pipeline. Viatris has made important changes to its business that should pay off down the road.
3 Pharmaceutical Stocks to Buy Hand Over Fist in March
09:28am, Monday, 11'th Mar 2024
Pfizer is a rebound candidate that pays a hefty dividend while you wait. AbbVie has been broadening its product offerings to become more diversified.
1 Bruised Dividend Stock to Buy While It's Cheap, and 1 to Avoid
07:10pm, Sunday, 10'th Mar 2024
Just because a stock's price fell does not mean it will stay down forever. Pfizer has a long roadmap for how to regain its recent glory.
Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks
03:05pm, Sunday, 10'th Mar 2024
The catalyst for top weight-loss stocks comes down to one sweeping attribute: a burgeoning total addressable market. According to a Goldman Sachs analysis, earlier last year, the global industry for a
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
08:00am, Sunday, 10'th Mar 2024
The pharmaceutical giant has been trying to shore up investor sentiment after its shares fell more than 40% in 2023.
6 Absolutely Best Dividend Stocks Yielding Over 6%
03:15pm, Saturday, 09'th Mar 2024
A financial advisor can help you understand the advantages and disadvantages of investment properties.
Wegovy and Zepbound Are King. Who's Coming for Their Crowns.
02:30am, Saturday, 09'th Mar 2024
Contenders are beginning to emerge from the lab, some with the potential to unseat Lilly's Zepbound and Novo's Wegovy.
6 Bargain Dividend Stocks To Buy
02:09pm, Friday, 08'th Mar 2024
The company offers medicines and vaccines in various therapeutic areas, including: Cardiovascular metabolic and women's health under the Premarin family and Eliquis brands Biologics, small molecules,
Beware Of Low Returns! Here Are 4 Dividend Stocks With Over 12% Annual Return Potential
08:00am, Friday, 08'th Mar 2024
Market sentiment is bullish but not at extreme levels, suggesting unusual developments in market sentiment, with surprisingly loose financial conditions.